[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 9,055
Sort by:

Hunter Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Hunter syndrome markets reached a value of US$ 702.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,152.5 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 130 pages

Hutchinson-Gilford Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Hutchinson-Gilford syndrome markets are expected to exhibit a CAGR of 6.53% during 2024-2034. The Hutchinson-Gilford Syndrome market has been comprehensively analyzed in IMARC's new report...

May 2024 133 pages

Hypereosinophilic Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypereosinophilic syndrome markets are expected to exhibit a CAGR of 9.32% during 2024-2034. The hypereosinophilic syndrome market has been comprehensively analyzed in IMARC's new report t...

May 2024 139 pages

Hypergammaglobulinemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypergammaglobulinemia markets are expected to exhibit a CAGR of 7.17% during 2024-2034. The hypergammaglobulinemia market has been comprehensively analyzed in IMARC's new report titled 'H...

May 2024 128 pages

Hyperhidrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hyperhidrosis markets reached a value of US$ 426.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 651.2 Million by 2034, exhibiting a growth rate (CAGR) of 3.92...

May 2024 133 pages

Hyperinsulinemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hyperinsulinemia markets reached a value of US$ 70.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 114.9 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 128 pages

Hyperkalemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hyperkalemia markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.47% dur...

May 2024 140 pages

Hyperlipoproteinemia Type II Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hyperlipoproteinemia type II markets are expected to exhibit a CAGR of 6.79% during 2024-2034. The hyperlipoproteinemia type II market has been comprehensively analyzed in IMARC's new repo...

May 2024 134 pages

Hyperparathyroidism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hyperparathyroidism markets are expected to exhibit a CAGR of 5.71% during 2024-2034. The hyperparathyroidism market has been comprehensively analyzed in IMARC's new report titled 'Hyperpa...

May 2024 132 pages

Hyperpigmentation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hyperpigmentation markets reached a value of US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6.6 Billion by 2034, exhibiting a growth rate (CAGR) of 6.38...

May 2024 133 pages

Hypersomnia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypersomnia markets are expected to exhibit a CAGR of 6.68% during 2024-2034. The hypersomnia market has been comprehensively analyzed in IMARC's new report titled 'Hypersomnia Market: Epi...

May 2024 129 pages

Hypertriglyceridemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypertriglyceridemia markets are expected to exhibit a CAGR of 3.52% during 2024-2034. The hypertriglyceridemia market has been comprehensively analyzed in IMARC's new report titled 'Hyper...

May 2024 137 pages

Hypertrophic Cardiomyopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypertrophic cardiomyopathy markets reached a value of US$ 312.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 356.7 Million by 2034, exhibiting a growth rate...

May 2024 132 pages

Hypertrophic Scar Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypertrophic scar markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.3 Billion by 2034, exhibiting a growth rate (CAGR) of 6.51...

May 2024 140 pages

Hyperuricemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hyperuricemia markets are expected to exhibit a CAGR of 8.93% during 2024-2034. The hyperuricemia market has been comprehensively analyzed in IMARC's new report titled 'Hyperuricemia Marke...

May 2024 140 pages

Hypogonadism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypogonadism markets reached a value of US$ 6.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.6 Billion by 2034, exhibiting a growth rate (CAGR) of 3.43% dur...

May 2024 133 pages

Hypoparathyroidism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypoparathyroidism markets are expected to exhibit a CAGR of 7.72% during 2024-2034. The hypoparathyroidism market has been comprehensively analyzed in IMARC's new report titled 'Hypoparat...

May 2024 136 pages

Hypophosphatasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypophosphatasia markets reached a value of US$ 725.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,036.4 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Hypoplastic Left Heart Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypoplastic left heart syndrome markets are expected to exhibit a CAGR of 8.4% during 2024-2034. The hypoplastic left heart syndrome market has been comprehensively analyzed in IMARC's new...

May 2024 136 pages

Hypothyroidism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypothyroidism markets are expected to exhibit a CAGR of 3.23% during 2024-2034. The hypothyroidism market has been comprehensively analyzed in IMARC's new report titled 'Hypothyroidism Ma...

May 2024 137 pages

Hypoxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major hypoxia markets are expected to exhibit a CAGR of 2.57% during 2024-2034. The hypoxia market has been comprehensively analyzed in IMARC's new report titled 'Hypoxia Market: Epidemiology, I...

May 2024 135 pages

Ichthyosiform Erythroderma/Congenital Ichthyosiform Erythroderma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ichthyosiform erythroderma/congenital ichthyosiform erythroderma markets are expected to exhibit a CAGR of 4.35% during 2024-2034. The ichthyosiform erythroderma/congenital ichthyosiform e...

May 2024 129 pages

Ichthyosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ichthyosis markets are expected to exhibit a CAGR of 4.12% during 2024-2034. The ichthyosis market has been comprehensively analyzed in IMARC's new report titled 'Ichthyosis Market: Epidem...

May 2024 139 pages

Idiopathic Intracranial Hypertension Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major idiopathic intracranial hypertension markets are expected to exhibit a CAGR of 6.53% during 2024-2034. The idiopathic intracranial hypertension (IIH) market has been comprehensively analyz...

May 2024 128 pages

Idiopathic Thrombocytopenic Purpura Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major idiopathic thrombocytopenic purpura markets are expected to exhibit a CAGR of 4.15% during 2024-2034. The idiopathic thrombocytopenic purpura market has been comprehensively analyzed in IM...

May 2024 137 pages

IgA Nephropathy (IgAN) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major IgA nephropathy (IgAN) markets reached a value of US$ 111.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 469.8 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 133 pages

Impetigo Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major impetigo markets are expected to exhibit a CAGR of 4.7% during 2024-2034. The impetigo market has been comprehensively analyzed in IMARC's new report titled 'Impetigo Market: Epidemiology,...

May 2024 128 pages

Indolent Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major indolent lymphoma markets are expected to exhibit a CAGR of 5.92% during 2024-2034. The indolent lymphoma market has been comprehensively analyzed in IMARC's new report titled 'Indolent Ly...

May 2024 133 pages

Inflammatory Bowel Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major inflammatory bowel disease markets are expected to exhibit a CAGR of 2.76% during 2024-2034. The inflammatory bowel disease market has been comprehensively analyzed in IMARC’s new report t...

May 2024 137 pages

Inflammatory Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major inflammatory pain markets reached a value of US$ 68.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 89.3 Billion by 2034, exhibiting a growth rate (CAGR) of 2....

May 2024 133 pages

Influenza B Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major influenza b markets reached a value of US$ 6.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 42.5 Million by 2034, exhibiting a growth rate (CAGR) of 19% durin...

May 2024 136 pages

Inguinal Hernia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major inguinal hernia markets are expected to exhibit a CAGR of 5.22% during 2024-2034. The inguinal hernia market has been comprehensively analyzed in IMARC's new report titled 'Inguinal Hernia...

May 2024 135 pages

Interstitial Cystitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major interstitial cystitis markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.3 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 128 pages

Interstitial Lung Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major interstitial lung disease markets reached a value of US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.1 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 130 pages

Intracranial Arterial Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major intracranial arterial diseases markets are expected to exhibit a CAGR of 3.92% during 2024-2034. The intracranial arterial diseases market has been comprehensively analyzed in IMARC's new...

May 2024 140 pages

Intratumoral Cancer Therapies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major intratumoral cancer therapies markets reached a value of US$ 148.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 303.4 Billion by 2034, exhibiting a growth rat...

May 2024 137 pages

Intravenous Immunoglobulin Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major intravenous immunoglobulin markets reached a value of US$ 12.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.5 Billion by 2034, exhibiting a growth rate (CA...

May 2024 139 pages

Invasive Candidiasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major invasive candidiasis markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 134 pages

Invasive Pneumococcal Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major invasive pneumococcal disease markets reached a value of US$ 6.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.0 Billion by 2034, exhibiting a growth rate (...

May 2024 132 pages

Iron Metabolism Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major iron metabolism disorders markets are expected to exhibit a CAGR of 3.55% during 2024-2034. The iron metabolism disorders market has been comprehensively analyzed in IMARC's new report tit...

May 2024 128 pages

Iron Overload Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major iron overload syndrome markets are expected to exhibit a CAGR of 3.91% during 2024-2034. The iron overload syndrome market has been comprehensively analyzed in IMARC's new report titled 'I...

May 2024 138 pages

Ischemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ischemia markets are expected to exhibit a CAGR of 3.91% during 2024-2034. The ischemia market has been comprehensively analyzed in IMARC's new report titled 'Ischemia Market: Epidemiology...

May 2024 130 pages

Ischemic Stroke Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ischemic stroke markets reached a value of US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.24%...

May 2024 134 pages

Isovaleric Acidemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major isovaleric acidemia markets are expected to exhibit a CAGR of 4.39% during 2024-2034. The isovaleric acidemia market has been comprehensively analyzed in IMARC's new report titled 'Isovale...

May 2024 130 pages

Kaposi's Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major kaposi's sarcoma markets reached a value of US$ 109.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 160.2 Million by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 137 pages

Kawasaki Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Kawasaki disease markets are expected to exhibit a CAGR of 5.33% during 2024-2034. The Kawasaki disease market has been comprehensively analyzed in IMARC's new report titled 'Kawasaki Dise...

May 2024 138 pages

Keloid Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major keloid markets are expected to exhibit a CAGR of 2.46% during 2024-2034. The keloid market has been comprehensively analyzed in IMARC's new report titled 'Keloid Market: Epidemiology, Indu...

May 2024 131 pages

Keratitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major keratitis markets are expected to exhibit a CAGR of 5.04% during 2024-2034. The keratitis market has been comprehensively analyzed in IMARC's new report titled 'Keratitis Market: Epidemiol...

May 2024 132 pages

Keratoconjunctivitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major keratoconjunctivitis markets are expected to exhibit a CAGR of 4.03% during 2024-2034. The keratoconjunctivitis market has been comprehensively analyzed in IMARC's new report titled 'Kerat...

May 2024 134 pages

Keratoconus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major keratoconus markets reached a value of US$ 202.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 275.0 Million by 2034, exhibiting a growth rate (CAGR) of 2.84%...

May 2024 139 pages

Filters

Search

Categories

350
112
93
266
20
68
26
8
13
3
1
1
1
1
1
3
201
128
113
3
260
245
20
8
2
60
2,180
2
1
1
5
4
386
195
1
231
4
284
282
2
2
7
6
5
5
4
4
3
2
2
2
2
2
2
3
4
2
1
1
2
2
5
23
5
1
1
1
145
12
1
2
1
1
5
10
1,316
942
767
28
8
7
6
5
5
5
4
4
3
3
3
3
1
1
1
1
1
1
1

Publishers

9,055

Regions

1
9,012
1
3
5
4
1
25
3

Price

Date

Pages

Offers

5,536